Endometriosis: the pathophysiology as an estrogen-dependent disease
review
OA: closed
CC0
⤵ 273 in-corpus citations
AI-generated summary
This review explores the pathophysiology of endometriosis, focusing on its development and progression as a disease driven by estrogen.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Endometriosis, defined as the presence of endometrial glands and stroma outside of the uterine cavity, develops mostly in women of reproductive age and regresses after menopause or ovariectomy, suggesting that the growth is estrogen-dependent. Indeed, the lesions contain estrogen receptors (ER) as well as aromatase, an enzyme that catalyses the conversion of androgens to estrogens, suggesting that local estrogen production may stimulate the growth of lesions. The expression patterns of ER and progesterone receptors in endometriotic lesions are different from those in the eutopic endometrium. Moreover, estrogen metabolism, including the expression pattern of aromatase and the regulation of 17 beta-hydroxysteroid dehydrogenase type 2 (an enzyme responsible for the inactivation of estradiol to estrone), is altered in the eutopic endometrium of women with endometriosis, adenomyosis, and/or leiomyomas compared to that in the eutopic endometrium of women without disease. Immunostaining for P450arom in endometrial biopsy specimens diagnosed these diseases with sensitivity and specificity of 91 and 100%, respectively. This is applicable to the clinical diagnosis of endometriosis. The polymorphisms in the ER-alpha gene, the CYP19 gene encoding aromatase, and several other genes are associated with the risk of endometriosis. Studies of these will lead to better understandings of the etiology and pathophysiology of endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (58)
- Aromatase expression in endometriosis. via openalex
- Association of estrogen receptor gene polymorphisms with endometriosis via openalex
- Association of the CYP17 gene and CYP19 gene polymorphisms with risk of endometriosis in Japanese women via openalex
- Characterization of messenger RNA expression of estrogen receptor-α and -β in patients with ovarian endometriosis via openalex
- Clinical usefulness of determination of estradiol level in the menstrual blood for patients with endometriosis. via openalex
- Deficient 17β-Hydroxysteroid Dehydrogenase Type 2 Expression in Endometriosis: Failure to Metabolize 17β-Estradiol<sup>1</sup> via openalex
- Detection of aromatase cytochrome P-450 in endometrial biopsy specimens as a diagnostic test for endometriosis via openalex
- Dominant Expression of Progesterone Receptor Form B mRNA in Ovarian Endometriosis via openalex
- Endometriosis: Immunohistochemical analysis of oestrogen and progesterone receptors in endometriotic tissue and endometrium via openalex
- Endometriosis: Oestrogen and progesterone receptors in endometriosis: heterogeneity of different sites via openalex
- Estrogen and progesterone receptors in endometriotic tissue and endometrium: comparison according to localization and recurrence via openalex
- Estrogen and progesterone receptors in endometriotic tissue and endometrium: comparison according to localization and recurrence. via openalex
- Estrogen and progestin receptors in endometriosis lesions: Comparison with endometrial tissue via openalex
- Estrogen biosynthesis in human uterine adenomyosis via openalex
- Evidence for estrogen synthesis in adenomyotic tissues via openalex
- Expression of Aromatase Cytochrome P450 Protein and Messenger Ribonucleic Acid in Human Endometriotic and Adenomyotic Tissues but not in Normal Endometrium1 via openalex
- Expression of estrogen and progesterone receptors in endometrium and peritoneal endometriosis: an immunohistochemical and in situ hybridization study via openalex
- Expression of estrogen receptor wild type and exon 5 splicing variant mRNAs in normal and endometriotic endometria during the menstrual cycle via openalex
- Expression of oestrogen receptor-alpha and -beta in ovarian endometriomata via openalex
- Familial endometriosis via openalex
- Genetic influences on endometriosis in an Australian twin sample via openalex
- Glutathione S-transferase M1 gene polymorphism and susceptibility to endometriosis in a French population via openalex
- Immunohistochemical analysis of estrogen and progesterone receptors in endometriosis: comparison with normal endometrium during the menstrual cycle and the effect of medical therapy via openalex
- Immunohistochemical characterization of proliferation, oestrogen receptor and progesterone receptor expression in endometriosis: comparison of eutopic and ectopic endometrium with normal cycling endometrium via openalex
- Linkage and association studies of the relationship between endometriosis and genes encoding the detoxification enzymes GSTM1, GSTT1 and CYP1A1 via openalex
- Ovarian steroid receptor expression in endometriosis and in two potential parent epithelia: endometrium and peritoneal mesothelium via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Possible involvement of arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 genes in the development of endometriosis via openalex
- Progesterone Induction of 17β-Hydroxysteroid Dehydrogenase Type 2 during the Secretory Phase Occurs in the Endometrium of Estrogen-Dependent Benign Diseases But Not in Normal Endometrium via openalex
- Progesterone Receptor Isoform A But Not B Is Expressed in Endometriosis via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis via openalex
- Ultrastructural changes in endometriotic implants during the menstrual cycle. via openalex
- W6658221620 via openalex
- W6663104962 via openalex
- W6668069468 via openalex
- W6684404551 via openalex
- W2009307286 via openalex
- W6716512485 via openalex
- W2005245112 via openalex
- W1978310578 via openalex
- W2058512318 via openalex
- W2063518962 via openalex
- W2066084415 via openalex
- W2069877703 via openalex
- W2089583450 via openalex
- W1972563403 via openalex
- W2105981541 via openalex
- W2131994528 via openalex
- W2149383746 via openalex
- W2154377312 via openalex
- W2163168485 via openalex
- W2223229280 via openalex
- W2411301886 via openalex
- W1912234690 via openalex
- W1672184366 via openalex
- W6609642172 via openalex
- W6656356435 via openalex
Cited by (50)
- Microbiome in women with endometriosis and the in vitro effects of Lactobacillus reuteri on human endometrium 2026
- Impact of hysteroscopy on pregnancy outcomes in women with endometriosis-associated infertility undergoing their first frozen-thawed embryo transfer: a retrospective cohort study 2026
- The interaction between inflammation and estrogen in adenomyosis : from molecular mechanisms to therapeutic strategies 2026
- The first case of ethanol sclerotherapy in 1998. Management of recurrent endometriosis after TAH+BSO – report of three cases 2026
- Comprendre les douleurs pelvi-périnéales chroniques liées à l’endométriose : le point de vue de l’algologue clinicien 2026
- Hormonal Treatment of Endometriosis: A Narrative Review 2025
- Patient satisfaction with two different management modalities for erratic bleeding during continuous hormone therapy for endometriosis-associated symptoms: A before-after study 2025
- Case of deep infiltrating and cystic endometriosis in a patient with a Müllerian anomaly: Surgical treatment by removing non-communicating horn 2025
- The Role of Hysterectomy in the Management of Endometriosis 2025
- Ethanol Sclerotherapy for Endometriomas in Infertile Women: A Narrative Review 2024
- An unusual case of bowel obstruction secondary to endometriosis 2024
- Endo Time: Endometriosis and the Flow of Recognition 2024
- Thymol Impacts the Progression of Endometriosis by Disrupting Estrogen Signaling Pathways and Inflammatory Responses 2024
- Endometriosis: Pathogenesis, Diagnosis and Treatment, volume II 2024
- Pancreatic endometriosis 2024
- Qualitative and Quantitative Tests on the Ingredients of Mahkota Dewa (Phaleria macrocarpa) Fruit Extract as an Alternative Therapy for Infertility in Endometriosis 2024
- Exercise and endometriosis-is there a promising future? A narrative review 2024
- Pain Management for Women with Endometriosis 2024
- Endometrial Receptivity in Women with Endometriosis 2024
- Gene expression of aromatase, SF-1, and HSD17B2 in menstrual blood as noninvasive diagnostic biomarkers for endometriosis 2024
- Eating for Optimization: Unraveling the Dietary Patterns and Nutritional Strategies in Endometriosis Management 2024
- Endometriosis-Associated Ovarian Carcinoma 2024
- Rapid reduction of adenomyosis coexisting with leiomyoma volume during treatment with Relugolix 2023
- The bidirectional relationship between endometriosis and microbiome 2023
- Potent Dual Inhibitors of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 with a Suitable Pharmacokinetic Profile for In Vivo Proof-of-Principle Studies in an Endometriosis Mouse Model 2023
- Endometriosis and infertility 2023
- CFP1 governs uterine epigenetic landscapes to intervene in progesterone responses for uterine physiology and suppression of endometriosis 2023
- Vanillin prevents the growth of endometriotic lesions through anti-inflammatory and antioxidant pathways in a mouse model 2023
- Cervical Cancer or Cervical Endometriosis – Review and Case Report 2023
- Regulation of HAND2 Expression by LncRNA HAND2-AS1 in Ovarian Endometriosis Involving DNA Methylation 2023
- Análise exploratória do miRNoma de células-tronco mesenquimais isoladas de fluxo menstrual de mulheres com endometriose 2023
- Ligustrazine: A Review of Its Role and Mechanism in the Treatment of Obstetrical and Gynecological Diseases 2023
- How Do Microorganisms Influence the Development of Endometriosis? Participation of Genital, Intestinal and Oral Microbiota in Metabolic Regulation and Immunopathogenesis of Endometriosis 2023
- Macrophages and small extracellular vesicle mediated-intracellular communication in the peritoneal microenvironment: Impact on endometriosis development 2023
- Medikamentöse Therapie der Endometriose – ein Update 2023
- HRT in Women Undergoing Pelvic Clearance for Endometriosis-A Case Report and a National Survey 2023
- Prise en charge de la douleur chez les patientes atteintes d’endométriose : proposition d’une stratégie thérapeutique 2023
- Microbiota in Irritable Bowel Syndrome and Endometriosis: Birds of a Feather Flock Together-A Review 2023
- Evaluation of aromatase expression in endometrioid heterotopias and endometria in patients with external genital endometriosis 2023
- Medikamentöse Therapie der Endometriose – ein Update 2022
- Papel de MICA na endometriose 2022
- Impact of lifestyle and diet on endometriosis: a fresh look to a busy corner 2022
- The Phytochemical Profile and Biological Activity of Malva neglecta Wallr. in Surgically Induced Endometriosis Model in Rats 2022
- Endometriosis-Associated Angiogenesis and Anti-angiogenic Therapy for Endometriosis 2022
- Hsa-mir-135a Shows Potential as A Putative Diagnostic Biomarker in Saliva and Plasma for Endometriosis 2022
- The Role of mTOR and eIF Signaling in Benign Endometrial Diseases 2022
- Features of the reproductive tract microbiota in patients with genital endometriosis. A literature review 2022
- Molecular Targets for Nonhormonal Treatment Based on a Multistep Process of Adenomyosis Development 2022
- The protective effects of ritodrine against hypoxia/reoxygenation-induced injury in endometrial stromal cells 2022
- Therapeutic Effect of Bromocriptine as a Dopamine Agonist on Endometrioma Size: A Double-Blind Randomized Controlled Trial 2022
Source provenance
- europepmc
- last seen: 2026-10-03T06:16:46.921020+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:12:55.732728+00:00
License: CC0
· commercial use OK